| Albayrak, Celal (ALRISE Biosystems 201005 Managing Director) |
Managing Director |
Alrise Biosystems GmbH |
Germany |
| Albani, Stephan (Univ Oldenburg 201101 Managing Director HörTech gGmbH + Hörzentrum Oldenburg GmbH) |
Managing Director |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
| Alba, Florent (NewCap 201502) |
Public Relations Manager / Investor Relations Manager |
NewCap. – Investor Relations & Financial Communications |
France |
| Alavijeh, Mohammad (Pharmidex 200602 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pharmidex Pharmaceutical Services Ltd. |
United Kingdom (GB) |
| Alatovic, Jasmina (BioNTech 202005 Senior Manager Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Alanine, Alexander (Bactevo 201704– COO before Roche) |
Chief Operating Officer (COO) |
Astellas (Group) |
United Kingdom (GB) |
| Alambeigi, Behrouz (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
| Alamaa, Marie-Louise (PledPharma 202011 CFO) |
Chief Financial Officer (CFO) |
Egetis Therapeutics (Group) |
Sweden |
| Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sigrid Therapeutics AB |
Sweden |
| Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) |
Chief Financial Officer (CFO) |
Kronos Bio Inc. (Nasdaq: KRON) |
United States (USA) |
| Al-Olayan, Abdurahman (Dammam Valley 202209 CEO) |
Chief Executive Officer (CEO) |
Saudi Arabia (govt) |
Saudi Arabia |
| Al-Khattawi, Ali (Mesox 2021– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Olgram SAS |
France |
| Al-Halabi-Frenzel, Laila (Abcalis GmbH 202312 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abcalis GmbH |
Germany |
| Akkermans, Michel |
n. a. |
|
|
| Akkerman, Ina (mei:do concepts GmbH 201211 Director Marketing + Communication before Norgenta) |
Public Relations Manager / Investor Relations Manager |
mei:do concepts GmbH |
Germany |
| Akkaraju, Srinivas (Srini) (Samsara BioCaptial 2016– Founder before Sofinnova Ventures + New Leaf Venture Partners) |
Investment Manager |
Samsara BioCapital (US) |
United States (USA) |
| Akira, Shizuko (Osaka (govt) 202210 President of OSaka Bio Headquarters) |
Cluster Manager |
Osaka (govt region) |
Japan |
| Akhmedov, Murodzhon (BigOmics 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BigOmics Analytics S.A. |
Switzerland |
| Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures AS |
Norway |
| Akatsuka, Hiroyuki (Osaka (govt) 202210 Associate Director of Life Sciences Industry Division) |
Administrative Officer (personnel) |
Osaka (govt region) |
Japan |
| Aiwanger, Hubert (Bavaria (govt) 201904 State Minister of Economic Affairs + Regional Development + Energy) |
Minister |
Bavaria (govt region) |
Germany |
| Aivaliotis, Michalis (FORTH 201202 IMBB-FORTH) |
n. a. |
FORTH (Foundation for Research and Technology – Hellas) |
Greece |
| Aitman, Tim (CSC/Imperial College London 200503) |
Professor |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Aitkenhead, Mark (Element Biosciences 202205– Chief Commercial Officer before at Thermo Fisher since 2003) |
Chief Commercial Officer (CCO) |
Element Biosciences Inc. |
United States (USA) |
| Aithani, Lakshyaditya Singh (Laksh) (Charm Therapeutics 202206 CEO + Co-Founder before Braavos + Exscientia + genei) |
Chief Executive Officer (CEO) |
Charm Therapeutics Ltd. |
United Kingdom (GB) |
| Aisher, Patrick (Kinled 202104 at Kinled Austria) |
Investment Manager |
Kinled (Group) |
Austria |
| Aiolfi, Franco (Biohit 201304– CEO of Biohit Italy before EuroClone) |
Chief Executive Officer (CEO) |
Biohit (Group) |
Italy |
| Aiguabella Font, Nuria (Bayer 202108 Global Communications Bayer Pharma New Modalities) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Aigner, Ilse (Germany (govt) 201101 Minister BMELV) |
Minister |
Germany (govt) |
Germany |
| Aiach, Karen (Lysogene 201206 CEO + Founder) |
Chief Executive Officer (CEO) |
Lysogene S.A. (Euronext Paris: LYS) |
France |
| Ahrent, Esther (Olympus Life + Material Science Europa GmbH 200704 Section Manager Marketing Comm Microscopy) |
n. a. |
Olympus (Group) |
Germany |
| Ahrens, Nikolai (Turos Capital 2018– Founder + CEO + LifeScience Connect 2020 Founder) |
n. a. |
Turos Capital AG |
Switzerland |
| Ahrens, Brent (Canaan Partners 201603 General Partner) |
General Partner (venture partner) |
Canaan Partners (Group) |
United States (USA) |
| Ahomäki, Satu (Orion Corp 202001 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Orion Corporation (Group) |
Finland |
| Ahnfeld, Oliver (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
| Ahmed, Nadim (BMS 202109 EVP) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Ahmed, J. Omee (Alto Marketing 201512) |
Public Relations Manager / Investor Relations Manager |
Alto Marketing Ltd. |
United Kingdom (GB) |
| Ahmati, Besmire (Gilde Investment 202306– Associate IR + Fundraising at Gilde Healthcare before PGGM + FMO) |
Public Relations Manager / Investor Relations Manager |
Gilde Investment (Group) |
Netherlands |
| Ahmadi, Khatereh (Merck (US) 201810 Executive Director Business Development + Licensing) |
Business Development Manager / Strategy Manager |
Merck (US) (MSD) (Group) |
United States (USA) |
| Ahlers, Sabine |
n. a. |
DEWB AG |
Germany |
| Ahlers, Benedikt (Florenus AG 200912– Executive Director + Founder before IP Bewertungs AG Head Sales + Developm) |
Board member, executive |
Florenus AG |
Germany |
| Ahlberg, Christopher (Spotfire 200505 CEO) |
Chief Executive Officer (CEO) |
TIBCO Software (Group) |
United States (USA) |
| Ahlberg, Christer (Cinclus Pharma 202106– CEO before Sedana Medical Group) |
Chief Executive Officer (CEO) |
Cinclus Pharma (Group) |
Sweden |
| Ahanola, Jani (Noona Healthcare 201611 CEO) |
Chief Executive Officer (CEO) |
Noona Healthcare (FI) |
Finland |
| Agus, David (Ellison Institute for Transformative Medicine 202205 Co-Founder) |
Company Founder |
Lawrence J. Ellison Institute for Transformative Medicine |
United States (USA) |
| Aguilar, Luc (L’Oréal 201402 Head of Biotechnologies Dept) |
President/Director/Head Business Group/Unit/Division |
L’Oréal (Group) |
France |
| Aguilar, Carolina (Inbrain Therapeutics 202103 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Inbrain Neuroelectronics S.L. |
Spain (España) |
| Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) |
Chief Executive Officer (CEO) |
Calliditas Therapeutics (Group) |
Sweden |
| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
| Aguiar, Michael (Theravance 200601 Senior VP + CFO) |
Chief Financial Officer (CFO) |
Innoviva (Group) |
United States (USA) |
| Agu, Chukwuma (ABS Biotechnologies GmbH 202401 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ABS Biotechnologies GmbH |
Austria |
| Agrawal, Bhuwnesh (Sysmex 202004– Managing Director (CEO) of Sysmex Inostics GmbH before Eppendorf + Vela Dx + Roche) |
Managing Director |
Sysmex (Group) |
Germany |
| Agostino-Etchetto, Florence (Lyonbiopole 201306– Managing Director joined 201209 before Hospices Civils de Lyon) |
Cluster Manager |
Lyonbiopôle |
France |
| Agon, Jean-Paul (L’Oréal 201812 CEO) |
Chief Executive Officer (CEO) |
L’Oréal (Group) |
France |
| Agnus, Jean-Baptiste (JB) (JSR Corp 202404– CBO at KBI Biopharma before AGC Biologics + Ajinomoto Bio-Pharma + Novasep) |
Chief Business Officer (CBO) |
JSR Corporation (Group) |
United States (USA) |
| Agneter, Doris (Niederösterreich (govt) 200511 Managing Director of N.vest + Tecnet Equity) |
Managing Director |
Niederösterreich (govt region) |
Austria |
| Agmoni, Eyal (Chartered Group 201910 Chairman) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Chartered Group |
|
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) |
Managing Partner (investment firm) |
Lundbeck (Group) |
Denmark |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) |
n. a. |
Aureon Laboratories Inc. |
United States (USA) |
| Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) |
Managing Director |
Blue Owl Capital (Group) |
United States (USA) |
| Agarwal, Shefali (Onxeo 202201 Board Chairwoman) |
Board member, non-executive |
Onxeo (Group) |
France |
| Agamirzian, Igor (Russia (govt) 201203 CEO of RVC Russian Venture Capital) |
Chief Executive Officer (CEO) |
Russia (govt) |
Russian Federation |
| Afshar, Mohammad (Ariana Pharmaceuticals 2002– CEO + Founder) |
Chief Executive Officer (CEO) |
Ariana Pharmaceuticals (Group) |
France |
| Afshar, Ali (Cytera Cellworks 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cytera CellWorks Ltd. |
United Kingdom (GB) |
| Afonso, Carlos (Univ Rouen 201606) |
Laboratory Manager (industry) |
University of Rouen (Université de Rouen) |
France |
| Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins) |
Chief Business Officer (CBO) |
UV-Cap (Vetter family office) (Group) |
Germany |
| Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) |
Chief Executive Officer (CEO) |
Affentranger Associates S.A. |
Switzerland |
| Affara, Nabeel (Cambridge Univ Molecular Genetics Group 200211) |
n. a. |
University of Cambridge |
United Kingdom (GB) |
| Affagard, Hervé (MaaT Pharma 201507 CEO) |
Chief Executive Officer (CEO) |
MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) |
France |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) |
Chief Executive Officer (CEO) |
Flagship Pioneering |
United States (USA) |
| af Winklerfelt, Michael (Oasmia 202008 CFO) |
Chief Financial Officer (CFO) |
Oasmia Pharmaceutical AB |
Sweden |
| Aebischer, Patrick (Ecole Polytechnique Fédérale 200808) |
n. a. |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Adulamy, Maya (Valo Health 202012– Head of Strategic Partnerships based in Israel before at Maccabi) |
Business Development Manager / Strategy Manager |
Valo Health (Group) |
United States (USA) |
| Adorján, Péter (Centogene 201502– Chief Business Development Officer before Epigenomics) |
Business Development Manager / Strategy Manager |
Centogene (Group) |
Germany |
| Adomat, Jens (Analytik Jena 1990–201312 Deputy Chairman of Executive Management Board + Co-founder LEFT 12/13) |
Board member, executive |
Endress+Hauser (Group) |
Germany |
| Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Admon, Arie (Technion 201008 Prof Dept of Biology + Head Smoler Proteomics Center) |
Professor |
Technion – Israel Institute of Technology |
Israel |
| Adlkofer, Kathrin (ai:do concepts GmbH 20111– Managing Director before Norgenta 2005–201202 Managing Director) |
Managing Director |
Cellbox Solutions (Group) |
Germany |
| Adlersson, Lars (Medivir 200609 CEO + President) |
Chief Executive Officer (CEO) |
Medivir (Group) |
Sweden |
| Adler-Beutgen, Amalia (Fujifilm 200706 Product Manager Diagnostics) |
n. a. |
Fujifilm (Group) |
Germany |
| Adlam, Leila (Inizio 202401 at Medistrava Consulting) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
| Adkins, John (Sterilin 200806 CEO) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United Kingdom (GB) |
| Adiri, Yonatan (Healthy.io 201909 CEO + Founder) |
Chief Executive Officer (CEO) |
Healthy.io Ltd. |
Israel |
| Adewoye, Henry (Compugen 201803– CMO before Gilead Sciences + Amgen) |
Chief Medical Officer (CMO) |
Compugen (Group) |
Israel |
| Adermann, Knut (AMP-Therapeutics GmbH 201210 Managing Director) |
Managing Director |
Spexis (Group) |
Germany |
| Adermann, Knut (AMP Biosimilars AG 201504 COO) |
Chief Technology/Technical Officer (CTO) |
AMP Biosimilars AG |
Germany |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) |
Chief Executive Officer (CEO) |
Sebia (Group) |
France |
| Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) |
Board member, non-executive |
Takeda (Group) |
United States (USA) |
| Adelhelm, Karin (Clondiag 200502) |
n. a. |
Abbott (Group) |
Germany |
| Ade, Michael (Strammer 201610 Partner + Top Management Consultant before Euromedica + Cellca + Ingenium) |
n. a. |
Strammer (Group) |
Germany |
| Adamski, J. (Helmholtz Zentrum München 200805 Head Gene Analysis Centre) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) |
Chief Executive Officer (CEO) |
Pairwise (Group) |
United States (USA) |
| Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) |
Chief Financial Officer (CFO) |
ObsEva (Group) |
Switzerland |
| Adams, Thorsten (Sartorius 201705 Director of Product Management for Fermentation Technologies at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
| Adams, Nicholas (Clavis Pharma 201107– CBO before Antisoma since 1999 BusDev Director + Manager + Ciba-Geiga + Eisai) |
Chief Business Officer (CBO) |
Aqualis ASA |
Norway |
| Adams, Julian (Gamida Cell 201906 CEO) |
Chief Executive Officer (CEO) |
Gamida Cell Ltd. (Nasdaq: GMDA) |
Israel |
| Adams, Jan (Apollo Health Ventures 202109– Venture Partner before Merck KGaA + EMBL Ventures) |
Venture Partner |
Apollo Health Ventures (Group) |
Germany |
| Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) |
Chief Executive Officer (CEO) |
Dainippon Sumitomo (Group) |
United States (USA) |
| Adamkiewicz, Maciej (Adamed 201108 CEO) |
Chief Executive Officer (CEO) |
Adamed (Group) |
Poland |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 167 168 169 
Person
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
